COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

SARS-CoV-2 virus infection of Peromyscus leucopus demonstrates that infection tolerance is not limited to agents for which deermice are reservoirs
Milovic, A., Gach, J. S., Chatzistamou, I., Olivarria, G. M., Lane, T. E., Forthal, D. N., Barbour, A. G.
10.64898/2026.03.13.711660 — Posted: 2026-03-15
TMEM106B mediates ACE2-independent replication of the SARS-CoV-2 S-E484D variant in airway-derived cell models
Xia, M., Wang, Q., Puray-Chavez, M., LaPak, K., Palakurty, S., Liu, Z., Cornejo Pontelli, M., Hui, S., Fremont, D. H., Diamond, M. S., Whelan, S. P. J., Major, M. B., Goldfarb, D., Kutluay, S. B.
10.64898/2026.03.14.711762 — Posted: 2026-03-15
Identification and Masking of Artefactual and Misleading Within-Host Variants in Deep-Sequencing SARS-CoV-2 Data
Anker, K. M., Hall, M., Evans Pena, R., Kemp, S. A., Clarke, J., Zhao, L., Bonsall, D., Grayson, N., Bashton, M., The COVID-19 Genomics UK (COG-UK) Consortium, , Walker, A. S., Golubchik, T., Lythgoe, K.
10.64898/2026.03.13.711550 — Posted: 2026-03-13
Epistasis and the changing fitness landscapes of SARS-CoV-2
Sesta, L., Neher, R. A.
10.64898/2026.03.12.711354 — Posted: 2026-03-13
Spike Antibody Fc Drives Protection from SARS-CoV-2 Challenge in Macaques
Brady, C., Govender, M., Mellors, J., Tipton, T., Gooch, K., Tomic, A., Carroll, M. W.
10.64898/2026.03.13.711527 — Posted: 2026-03-13
Deep mutational scanning of recent SARS-CoV-2 variants highlights changing amino acid preferences within epistatic hotspot residues
Taylor, A., Starr, T. N.
10.64898/2026.03.11.711006 — Posted: 2026-03-13
Physician-scientist hiring practices at US universities before and after the COVID-19 pandemic
Noch, E. K., Obradovic, A., Jain, S., Kwan, J. M.
10.64898/2026.03.04.26347529 — Posted: 2026-03-12
Horizon-dependent forecast ranking under structural change: a rolling-origin benchmark for global COVID-19 incidence
Sesay, M. M., Wembo, M. S.
10.64898/2026.03.11.26348121 — Posted: 2026-03-12
Discovery of Semicarbazone and Thiosemicarbazone Analogs as Competitive SARS-CoV-2 Virus Main Protease (Mpro) Inhibitors
Barreto, L. V., Lourenco, E. M. G., da Silva, E. B., de Godoy, M. O., Martins, L. C., Laureano de Souza, M., Almeida, R. G., Cunha, V. L. S., Pires, M. C., Lavorato, S. N., de Souza, T. B., Bretas, A. C. O., Ottoni, F. M., Junior, E. N. S., Oliva, G., Alves, R. J., de Oliveira, R. B., Guido, R. V. C., Ferreira, R. S.
10.64898/2026.03.11.711159 — Posted: 2026-03-12
Persistent SARS-CoV-2 Spike is Associated with Localized Immune Dysregulation in Long COVID Gut Biopsies
Abraham Soria, S., Peterson, P., VanElzakker, M. B., Tankelevich, M., Mehandru, S., Proal, A., Putrino, D., Freire, M.
10.64898/2026.03.09.707564 — Posted: 2026-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).